ScholarIQanswers from OpenAlex

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

PaperCitations, authors & open-access status

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma have?

ScholarIQcitation count

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma has 1,452 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma published?

ScholarIQyear

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma has 2012 year in the ScholarIQ index.

What is the open-access status of Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma?

ScholarIQoa status

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma has green oa status in the ScholarIQ index.

What is the DOI of Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma?

ScholarIQdoi

The DOI for Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma is on the source record.

What is the PMID of Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma?

ScholarIQpmid

The PMID for Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma is on the source record.

What is the OpenAlex record for Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma?

ScholarIQopenalex

The OpenAlex for Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial